NYSE:USNA USANA Health Sciences (USNA) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free USNA Stock Alerts $48.50 +0.23 (+0.48%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$48.29▼$48.9050-Day Range$46.47▼$52.3652-Week Range$44.01▼$69.60Volume72,291 shsAverage Volume77,959 shsMarket Capitalization$933.14 millionP/E Ratio14.70Dividend YieldN/APrice Target$48.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get USANA Health Sciences alerts: Email Address USANA Health Sciences MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside1.0% Downside$48.00 Price TargetShort InterestHealthy2.26% of Float Sold ShortDividend StrengthN/ASustainability-2.09Upright™ Environmental ScoreNews Sentiment0.38Based on 3 Articles This WeekInsider TradingSelling Shares$1.20 M Sold Last QuarterProj. Earnings Growth14.65%From $2.73 to $3.13 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.42 out of 5 starsMedical Sector340th out of 938 stocksMedicinals & Botanicals Industry2nd out of 11 stocks 1.3 Analyst's Opinion Consensus RatingUSANA Health Sciences has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $48.00, USANA Health Sciences has a forecasted downside of 1.0% from its current price of $48.50.Amount of Analyst CoverageUSANA Health Sciences has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.26% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in USANA Health Sciences has recently increased by 49.44%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. Previous Next 2.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreUSANA Health Sciences has received a 24.21% net impact score from Upright. The largest positive contribution comes from its "Nutrition" impact, which is mostly driven by its "Direct selling of dietary supplements through representatives", "Direct selling of nutritional products through representatives", and "Direct selling of skincare products through representatives" products. See details.Environmental SustainabilityThe Environmental Impact score for USANA Health Sciences is -2.09. Previous Next 3.0 News and Social Media Coverage News SentimentUSANA Health Sciences has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for USANA Health Sciences this week, compared to 2 articles on an average week.Search Interest1 people have searched for USNA on MarketBeat in the last 30 days. MarketBeat Follows4 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,200,791.00 in company stock.Percentage Held by InsidersOnly 0.33% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 14.65% in the coming year, from $2.73 to $3.13 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is 14.70, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 141.11.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is 14.70, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 212.34.Price to Earnings Growth RatioUSANA Health Sciences has a PEG Ratio of 1.45. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 1.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About USANA Health Sciences Stock (NYSE:USNA)USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.Read More USNA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart USNA Stock News HeadlinesMarch 12, 2024 | insidertrades.comUSANA Health Sciences, Inc. (NYSE:USNA) COO Walter Noot Sells 5,240 SharesMarch 25, 2024 | finance.yahoo.comSome Investors May Be Worried About USANA Health Sciences' (NYSE:USNA) Returns On CapitalMarch 28, 2024 | DTI (Ad)the most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.March 16, 2024 | finance.yahoo.comUSNA Apr 2024 45.000 putMarch 11, 2024 | finance.yahoo.comUsana Health Sciences Inc (USNA) Executive Chairman of the Board Kevin Guest Sells 11,011 SharesMarch 6, 2024 | finance.yahoo.comUsana Health Sciences Inc (USNA) Chief Scientific Officer Robert Sinnott Sells Company SharesMarch 4, 2024 | finance.yahoo.comUsana Health Sciences Inc's Chief Legal Officer Joshua Foukas Sells Company SharesFebruary 28, 2024 | prnewswire.comKevin Guest Says Leap Forward on Leap DayMarch 28, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionFebruary 22, 2024 | prnewswire.comUSANA Sustainability and DEI Executive Director Awarded in UtahFebruary 14, 2024 | finance.yahoo.comJim Simons Adjusts Position in Usana Health Sciences IncFebruary 8, 2024 | finance.yahoo.comUSANA Health Sciences Full Year 2023 Earnings: EPS Beats ExpectationsFebruary 8, 2024 | finance.yahoo.comUSANA Health Sciences, Inc. (NYSE:USNA) Q4 2023 Earnings Call TranscriptFebruary 7, 2024 | finance.yahoo.comUSANA Health Sciences (USNA) Q4 Earnings and Revenues Beat EstimatesFebruary 6, 2024 | finance.yahoo.comUsana Health Sciences Inc (USNA) Reports Mixed Fiscal Year 2023 ResultsFebruary 6, 2024 | markets.businessinsider.comUSANA Health Sciences Q4 Income Climbs, Beats estimatesFebruary 6, 2024 | finance.yahoo.comUSANA (NYSE:USNA) Q4 Sales Beat EstimatesFebruary 1, 2024 | finance.yahoo.comKevin Guest Calls on All to Connect during February Month of FriendshipFebruary 1, 2024 | finance.yahoo.comEuromonitor International names USANA Malaysia and Singapore Top #1 Brand for Probiotic Supplements When CombinedJanuary 29, 2024 | finance.yahoo.comUnpacking Q3 Earnings: USANA (NYSE:USNA) In The Context Of Other Personal Care StocksJanuary 25, 2024 | finance.yahoo.comUSANA Manufacturing Facility Receives Coveted GFSI Certification from SQFJanuary 23, 2024 | finance.yahoo.comUSANA to Continue Investing in Local Community after Decades-Long Amphitheatre Sponsorship EndsJanuary 21, 2024 | finance.yahoo.comDeclining Stock and Decent Financials: Is The Market Wrong About USANA Health Sciences, Inc. (NYSE:USNA)?January 16, 2024 | finance.yahoo.comUSANA Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference CallJanuary 10, 2024 | theglobeandmail.comUnpacking Q3 Earnings: Nature's Sunshine (NASDAQ:NATR) In The Context Of Other Personal Care StocksJanuary 3, 2024 | finance.yahoo.comKevin Guest Names 2024 the Year of ConnectionJanuary 3, 2024 | finance.yahoo.comUSANA Named No. 1 Vitamins and Dietary Supplements Brand in PhilippinesSee More Headlines Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/06/2024Today3/28/2024Next Earnings (Estimated)4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medicinals & botanicals Sub-IndustryPersonal Products Current SymbolNYSE:USNA CUSIP90328M10 CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,800Year FoundedN/APrice Target and Rating Average Stock Price Target$48.00 High Stock Price Target$48.00 Low Stock Price Target$48.00 Potential Upside/Downside-1.0%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$3.30 Trailing P/E Ratio14.70 Forward P/E Ratio17.77 P/E Growth1.45Net Income$63.79 million Net Margins6.93% Pretax Margin11.12% Return on Equity13.49% Return on Assets10.45% Debt Debt-to-Equity RatioN/A Current Ratio3.52 Quick Ratio3.00 Sales & Book Value Annual Sales$921.01 million Price / Sales1.01 Cash Flow$4.49 per share Price / Cash Flow10.80 Book Value$25.99 per share Price / Book1.87Miscellaneous Outstanding Shares19,240,000Free Float19,178,000Market Cap$933.14 million OptionableOptionable Beta0.90 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Kevin G. Guest (Age 61)Executive Chairman Comp: $1.29MMr. Jim Brown (Age 55)CEO & President Comp: $790.56kMr. G. Douglas Hekking (Age 54)Chief Financial Officer Comp: $648.81kMr. Walter Noot (Age 58)Chief Operating Officer Comp: $624.56kMr. David Mulham (Age 64)Chief Field Development Officer Comp: $601.72kDr. Myron W. Wentz (Age 83)Founder & Chairman Emeritus Dr. John CuomoExecutive Director of Product Development & TechnologyDr. Robert A. Sinnott M.N.S. (Age 59)Ph.D., Chief Scientific Officer Mr. Patrique RichardsExecutive Director of Investor Relations & Business DevelopmentMr. P. Joshua Foukas (Age 48)Chief Legal Officer, General Counsel & Corporate Secretary More ExecutivesKey CompetitorsCronos GroupNASDAQ:CRONCanopy GrowthNASDAQ:CGCbioteNASDAQ:BTMDMind Medicine (MindMed)NASDAQ:MNMDChromaDexNASDAQ:CDXCView All CompetitorsInsiders & InstitutionsPNC Financial Services Group Inc.Sold 337 shares on 3/22/2024Ownership: 0.003%Vanguard Group Inc.Bought 15,560 shares on 3/11/2024Ownership: 8.201%Kevin GuestSold 11,011 sharesTotal: $539,539.00 ($49.00/share)Walter NootSold 5,240 sharesTotal: $257,022.00 ($49.05/share)Robert A. SinnottSold 3,945 sharesTotal: $183,639.75 ($46.55/share)View All Insider TransactionsView All Institutional Transactions USNA Stock Analysis - Frequently Asked Questions Should I buy or sell USANA Health Sciences stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" USNA shares. View USNA analyst ratings or view top-rated stocks. What is USANA Health Sciences' stock price target for 2024? 2 Wall Street research analysts have issued twelve-month target prices for USANA Health Sciences' stock. Their USNA share price targets range from $48.00 to $48.00. On average, they anticipate the company's share price to reach $48.00 in the next twelve months. This suggests that the stock has a possible downside of 1.0%. View analysts price targets for USNA or view top-rated stocks among Wall Street analysts. How have USNA shares performed in 2024? USANA Health Sciences' stock was trading at $53.60 at the start of the year. Since then, USNA shares have decreased by 9.5% and is now trading at $48.50. View the best growth stocks for 2024 here. Are investors shorting USANA Health Sciences? USANA Health Sciences saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 255,100 shares, an increase of 49.4% from the February 29th total of 170,700 shares. Based on an average daily trading volume, of 76,200 shares, the short-interest ratio is presently 3.3 days. Approximately 2.3% of the company's shares are sold short. View USANA Health Sciences' Short Interest. When is USANA Health Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024. View our USNA earnings forecast. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) issued its quarterly earnings results on Tuesday, February, 6th. The company reported $0.87 earnings per share for the quarter, beating analysts' consensus estimates of $0.52 by $0.35. The firm earned $221.08 million during the quarter, compared to analysts' expectations of $206.70 million. USANA Health Sciences had a trailing twelve-month return on equity of 13.49% and a net margin of 6.93%. What ETFs hold USANA Health Sciences' stock? ETFs with the largest weight of USANA Health Sciences (NYSE:USNA) stock in their portfolio include Invesco S&P SmallCap Consumer Staples ETF (PSCC), Roundhill Acquirers Deep Value ETF (DEEP), Global X Health & Wellness ETF (BFIT), ETC 6 Meridian Low Beta Equity Strategy ETF (SIXL), What guidance has USANA Health Sciences issued on next quarter's earnings? USANA Health Sciences issued an update on its FY 2024 earnings guidance on Tuesday, February, 6th. The company provided EPS guidance of 2.400-3.000 for the period, compared to the consensus earnings per share estimate of 2.940. The company issued revenue guidance of $850.0 million-$920.0 million, compared to the consensus revenue estimate of $912.3 million. What is Kevin Guest's approval rating as USANA Health Sciences' CEO? 68 employees have rated USANA Health Sciences Chief Executive Officer Kevin Guest on Glassdoor.com. Kevin Guest has an approval rating of 99% among the company's employees. This puts Kevin Guest in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include International Business Machines (IBM), Gilead Sciences (GILD), NVIDIA (NVDA), AT&T (T), BioMarin Pharmaceutical (BMRN), Vertex Pharmaceuticals (VRTX), AbbVie (ABBV), Walt Disney (DIS), Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ). Who are USANA Health Sciences' major shareholders? USANA Health Sciences' stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.27%), Vanguard Group Inc. (8.20%), Pzena Investment Management LLC (3.98%), Dimensional Fund Advisors LP (3.54%), Pacer Advisors Inc. (1.76%) and Charles Schwab Investment Management Inc. (1.16%). Insiders that own company stock include Brent Neidig, Daniel A Macuga, David Mulham Mulham, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Gilbert A Fuller, Jim Brown, John Turman Fleming, Joshua Foukas, Kevin Guest, Paul A Jones, Robert A Sinnott, Robert A Sinnott, Robert Auciaux, Walter Noot and Xia Ding. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:USNA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.